1. National HPV Vaccination Drive: Curbing Cervical Cancer

The Union Health Ministry is initiating a nationwide Human Papillomavirus (HPV) vaccination campaign to combat cervical cancer, primarily targeting adolescent girls. This move aligns with global health goals to eliminate one of the most common cancers among women in India. Key Highlights of the Programme • Target Demographic: The drive specifically targets girls aged 14 years to ensure maximum preventive efficacy before potential exposure to the virus. • Vaccine Type: India will utilize Gardasil, a quadrivalent vaccine that protects against HPV types 16 and 18 (responsible for most cervical cancers) and types 6 and 11 (linked to genital warts). • Single-Dose Efficacy: Clinical evidence suggests a single dose provides robust, long-term protection for the recommended age group, simplifying logistics and increasing coverage. • Universal Access: The vaccine will be provided free of cost and on a voluntary basis, aiming to bridge the socio-economic gap in preventive healthcare. • International Partnership: Procurement is facilitated through a partnership with Gavi, the Vaccine Alliance, ensuring a steady supply of WHO-prequalified vaccines that meet stringent cold-chain standards. • Implementation Strategy: The roll-out will be integrated into the existing immunization framework across all States and Union Territories to ensure seamless delivery. Important Definitions • Human Papillomavirus (HPV): A group of more than 200 related viruses, some of which are transmitted through sexual contact and can lead to various cancers, most notably cervical cancer. • Quadrivalent Vaccine: A vaccine designed to stimulate an immune response against four different antigens, such as the four specific strains of HPV targeted by Gardasil. • Cold Chain: A temperature-controlled supply chain necessary for maintaining the potency of vaccines from the point of manufacture to the point of administration. Constitutional and Legal Framework • Article 21: The Right to Life includes the right to health and affordable medical treatment, as interpreted by the Supreme Court. • Article 47 (DPSP): Mandates the State to regard the improvement of public health as among its primary duties. • Universal Immunization Programme (UIP): While initially focused on childhood diseases, the expansion to include HPV aligns with the National Health Policy 2017\'s goal of reducing premature mortality from non-communicable diseases. Additional Key Insights • Disease Burden: India accounts for nearly one-fifth of the global cervical cancer burden, with approximately 1.25 lakh new cases and over 75,000 deaths reported annually. • Indigenization: While Gardasil is currently being used, India\'s first indigenous HPV vaccine, CERVAVAC (developed by the Serum Institute of India), is expected to play a critical role in future scale-ups to ensure \'Atmanirbharta\' in vaccine production. • Preventive Economics: Investing in HPV vaccination significantly reduces the long-term healthcare expenditure associated with cancer treatment and palliative care. Conclusion The rollout of the free HPV vaccination drive marks a transformative shift in India’s public health strategy, moving from curative to preventive oncology. By targeting the high-risk adolescent window and ensuring equitable access, the government is taking a decisive step toward the eventual elimination of cervical cancer, ultimately improving women’s health outcomes and life expectancy across the nation. UPSC Relevance • GS Paper II: Social Justice (Issues relating to development and management of Social Sector/Services relating to Health). • GS Paper III: Science and Technology (Developments and their applications and effects in everyday life; Indigenization of technology). • Prelims: HPV strains, vaccine types (quadrivalent), Gavi, and specific health-related articles of the Constitution.